Sorasitthiyanukarn, F.N.; Muangnoi, C.; Gomez, C.B.; Suksamrarn, A.; Rojsitthisak, P.; Rojsitthisak, P.
Potential Oral Anticancer Therapeutic Agents of Hexahydrocurcumin-Encapsulated Chitosan Nanoparticles against MDA-MB-231 Breast Cancer Cells. Pharmaceutics 2023, 15, 472.
https://doi.org/10.3390/pharmaceutics15020472
AMA Style
Sorasitthiyanukarn FN, Muangnoi C, Gomez CB, Suksamrarn A, Rojsitthisak P, Rojsitthisak P.
Potential Oral Anticancer Therapeutic Agents of Hexahydrocurcumin-Encapsulated Chitosan Nanoparticles against MDA-MB-231 Breast Cancer Cells. Pharmaceutics. 2023; 15(2):472.
https://doi.org/10.3390/pharmaceutics15020472
Chicago/Turabian Style
Sorasitthiyanukarn, Feuangthit N., Chawanphat Muangnoi, Clinton B. Gomez, Apichart Suksamrarn, Pranee Rojsitthisak, and Pornchai Rojsitthisak.
2023. "Potential Oral Anticancer Therapeutic Agents of Hexahydrocurcumin-Encapsulated Chitosan Nanoparticles against MDA-MB-231 Breast Cancer Cells" Pharmaceutics 15, no. 2: 472.
https://doi.org/10.3390/pharmaceutics15020472
APA Style
Sorasitthiyanukarn, F. N., Muangnoi, C., Gomez, C. B., Suksamrarn, A., Rojsitthisak, P., & Rojsitthisak, P.
(2023). Potential Oral Anticancer Therapeutic Agents of Hexahydrocurcumin-Encapsulated Chitosan Nanoparticles against MDA-MB-231 Breast Cancer Cells. Pharmaceutics, 15(2), 472.
https://doi.org/10.3390/pharmaceutics15020472